UT Southwestern Division of General Internal Medicine转发了
The Medicare Competitive Bidding Program was implemented in 2011 to reduce durable medical equipment prices. Legislation introduced in 2024 aims to remove supplemental oxygen from the Program due to concerns that decreases in oxygen prescribing are due to decreased supply and limited oxygen access for patients with chronic lung diseases -- driven by lower prices set by the Program. Conversely, low-value prescribing of oxygen is prevalent in practice, and decreased oxygen prescription rates may not have necessarily caused harm. What is the association between the Program and patient use, outcomes, or spending? Honored to work with a team from The University of British Columbia & University of Washington to add empiric evidence to the policy debate in an article published in JAMA Internal Medicine https://lnkd.in/gBJzSEsB